MEF2C and acute lymphoblastic leukemia: Our results demonstrated that CC1007 could effectively inhibit the expression of both HDAC7 and MEF2C, and reduced HDAC7 protein aggregation in the nuclei in BCR-ABL1− pre-B-ALL cells.